OTC market in Central Europe 2015 Comparative analysis and development forecasts for 2015-2020
  • Date of issue: October 2015
  • Pages: 249
  • Delivery: Pdf file

OTC market in Central Europe 2015

Comparative analysis and development forecasts for 2015-2020

This report contains the latest sales data and current market values for the entire over the counter pharmaceuticals market and the pharmacy, non-pharmacy and online segments. It provides coverage of OTC markets in six countries: Bulgaria, Hungary, Poland, Romania, Slovakia and the Czech Republic, enabling readers to compare and analyse conditions and outlooks quickly and accurately. The document is also a convenient source of trends analysis, regulatory updates and analysis and detailed forecasts for all markets and segments to 2020.

 

Assess, evaluate and locate business opportunities using…

  • Comparative analysis tools – view side-by side data on markets in six countries to learn about conditions and prospects for the future
  • Comprehensive analyses, including the impacts of trends, market events, consumer preferences and legal changes – in one cost-effective report
  • Historical data that provides context to growth expectations for OTC markets in Bulgaria, Hungary, Poland, Romania, Slovakia and the Czech Republic.

 

Examine all aspects of core market topics…

  • Best selling over the counter medications and supplements in each of the six highlighted countries
  • Manufacturing companies active on the OTC markets in Central Europe
  • Comparison of OTC market shares of the overarching pharmaceutical sectors in each country
  • Influential trends, consumer preferences and their impacts on the market, as perceived by experienced observers
  • Statistical data representing a wide variety of recent and current market elements, including value, growth and sales.

 

Learn important facts and data about the market...

Here we present just a small sample of information available in the report:

  • CEE markets are far from saturation. 
  • In Poland in the entire 2015, the recorded incidence of flu may turn out to be similar to the incidence reported a year ago.
  • The national herb strategy of Hungary was adapted in 2014.
  • The OTC product subgroup in the Czech Republic is dominated by large multinational companies.
  • In Slovakia, in terms of the ranking of the best-selling OTC drugs by volume, one of the highest average prices per packet in 2014 was reported in the case of products used in the treatment of respiratory tract diseases.
 

Have you ever inquired?

  • Which of the OTC markets in the CE countries of Bulgaria, Hungary, Poland, Romania, Slovakia and the Czech Republic is currently most saturated?
  • Which country’s OTC market is most business friendly in terms of regulation?
  • What is the direction and extent of predicted development in Central Europe’s OTC market? In each country?
  • What are the strategies of leading companies on the OTC markets in Central European countries?
  • Which country supports the OTC market with the highest value?

 

This report meets the business information needs of…

  • Online sellers of OTC medications and supplements
  • Management level personnel at OTC product manufacturers
  • Wholesale distribution companies active in this market
  • Government agencies and embassy officials
  • Research and consulting professionals and educators.

 

Extract from this report

  • The extension of the price freeze until the end of 2015 has led to a reduction in forecast growth for 2015 in comparison with the previous forecasts in Bulgaria. 
  • According to our estimates, in 2014, the OTC market grew by approximately 4% in Slovakia. This is not spectacular growth, given that the macroeconomic indicators improved in 2014. It was probably too early for this to be apparent in spending on drugs. On the other hand, the number of infections was lower than that of 2013. In 2014, as in the case of the Czech Republic, the main instruments of growth were new packets and new products which offset the reduction in the volume sales of older products. The increase in price and the marketing mix was, in particular, important in the case of OTC drugs, whereas the introduction of new packets and new products was more important in the case of non-drugs.
 

Market commentary by expert

"Nowadays, the countries of Central Europe face serious constraints in government spending on reimbursed drugs. Generally speaking, after financial crisis, financial resources are allocated more carefully. Manufacturers’ prices are cut and distributors’ margins strictly controlled. That is why, all the market players look for ways to compensate losses and they are focused more and more often on products sold without prescription (drugs, dietary supplements, dermocosmetics, functional food, etc. What is more, in some of the countries in the region, the distribution of reimbursed drugs is now more strictly controlled and that is why, OTC products started to be more popular. Our publication reveals more such market trends and combining them with hard data regarding OTC sales presents reliable forecast of the OTC market development till 2020."

 

Monika Stefańczyk, Head Pharma & Healthcare Market Analyst

 

PMR provides a good service and is always open to discussion. All reports are well structured & are always on time. Member of the Managment Board, SCA Hygiene Products
We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis. Senior Trade and Investment Adviser, British Embassy in Warsaw
PMR reports are a serious contribution to the market overview picture, focusing our attention on key events in the industry as well as highlighting both general and specific market indicators. Together, these components are the base for our future forecasts of construction market development and help us to plan our sales. Market Analyst, Alpha Cement
PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. Senior Trade and Investment Adviser, British Embassy in Warsaw
It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner. Business Analyst, Hilti Distribution, Russia
As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding. Development Manager, GVA Grimley

  • Methodology
  • Executive summary
    • CE region
    • Poland
    • Hungary
    • Romania
    • Czech Republic
    • Bulgaria
    • Slovakia
  • OTC market in the CE region
    • Comparative analysis of OTC markets
      • Share of individual OTC markets in 2013
      • Per capita OTC spending in CE countries
      • Value of OTC market in CE countries between 2011 and 2019
      • Average CAGR for OTC markets in CE countries in 2012-2013 and 2014-2019
  • Poland
    • Main trends and events on the OTC market
    • OTC market value
      • OTC market value by distribution channel
      • OTC market value by product status (drugs vs dietary supplements)
      • Share of OTC products as a proportion of the pharmaceutical market
      • Value of the OTC product market between 2009 and 2020
      • Value of the dietary supplement market between 2011 and 2019
      • OTC product market by therapeutic categories
      • Dietary supplement market by therapeutic categories
    • Prices of OTC products
    • Switch from Rx to OTC
    • Bestselling OTC products
      • OTC products
      • OTC drugs
      • Dietary supplements
    • Advertising
      • Legal framework
      • Spending on OTC advertising
    • Key players
      • OTC products
      • OTC drugs
      • Dietary supplements
      • Important events pertaining to companies present on the market
  • Hungary
    • Main trends and events on the OTC market
    • OTC market value
      • OTC market by distribution channel
      • OTC market value by product status (drugs vs dietary supplements)
      • Share of OTC products as a proportion of the pharmaceutical market
      • Value of the OTC product market between 2011 and 2020
      • Volume of the OTC drugs market between 2011 and 2014
      • Value of the dietary supplement market
      • OTC product market by therapeutic categories
    • Prices of OTC products
    • Switch from Rx to OTC
    • Bestselling OTC products
    • Advertising
      • Legal framework
      • Spending on OTC advertising
    • Key players
      • OTC drugs
      • Dietary supplements
      • Important events pertaining to companies present on the market
  • Romania
  • Czech Republic
  • Bulgaria
  • Slovakia
  • Profiles of selected manufacturers on the OTC market in CE

Graphs

  • Value (€ bn) and change (%, y-o-y) of the OTC product market in CE, 2011-2020
  • Share of individual OTC markets as a proportion of total OTC market in CE (%), 2014
  • Per capita spending on OTC products in CE countries (€), 2014
  • Value (€ bn) and change (%, y-o-y) of the OTC product market in CE, 2011-2020
  • Average CAGR for OTC markets in the CE countries analysed (%), 2012-2014
  • Average CAGR for OTC markets in the CE countries analysed (%), 2012-2014
  • Average CAGR for OTC markets in the CE countries analysed (%), 2015-2020
  • Frequency of consuming dietary supplements in Poland, by sex of respondents (%), August-October 2014
  • Place where respondents most often buy dietary supplements in Poland (%), August-October 2014
  • Number of OTC drugs authorised for marketing and dietary supplements notified in Poland, 2007 – January-May 2015
  • Incidence of flu in Poland (million), 2000 – January-June 2015
  • Proportion of Poles taking flu vaccinations in Poland (%), 2009/2010-2013/2014
  • OTC product market in Poland, by sales channel and value share (%), 2014
  • Pharmacy market of OTC drugs and dietary supplements in Poland, by product status, in terms of value, final prices (%), 2011-2014
  • Pharmacy market of OTC drugs and dietary supplements in Poland, by product status, in terms of volume (%), 2011-2014
  • Non-pharmacy sales of OTC products in Poland, by product status and value share (%), 2011-2014
  • OTC product market in Poland, by product status and value share (%), 2014
  • Share of OTC products in the pharmaceutical market in Poland (%), 2011 – January-May 2015
  • Value (PLN bn) and change (%) of the pharmacy market of OTC products in Poland, 2009-2020
  • Value (PLN bn) and change (%) of the dietary supplement market in Poland, 2011-2020
  • Pharmacy sales of selected OTC product categories in Poland (PLN m), manufacturer prices, 2014
  • Average prices of OTC products per packet in Poland (PLN) and change (%), 2005 – January-April 2015
  • Average pharmacy margin on OTC products in comparison with other pharmacy products in Poland (%), 2013 – January-April 2015
  • Number of changes in status from Rx to OTC medication in Poland, 2009 – January-May 2015
  • Number of changes in status from OTC to Rx medication in Poland, 2010 – January-May 2015
  • Advertising spending of companies in the pharmaceutical sector in Poland (PLN bn) and change (%), 2009-Q1 2015
  • Share of selected categories as a proportion of advertising spending of the pharmaceutical industry in Poland (%), February-March 2015
  • Share of individual media channels in advertising expenditure of the pharmaceutical sector in Poland (%), January-October 2013-2014
  • Share of individual media channels in advertising expenditure of the pharmaceutical sector in Poland (%), Q1 2014 and Q2015
  • Expenditure on TV advertising in the pharmaceutical sector in Poland (PLN m) and change (%), 2011-Q1 2015
  • Share of individual manufacturers as a proportion of TV advertising spending on OTC drugs in Poland (%), 1 March-14 April 2015
  • Share of individual manufacturers as a proportion of TV advertising spending on dietary supplements in Poland (%), 1 March-14 April 2015
  • Expenditure on radio advertising in the pharmaceutical sector in Poland (PLN m) and change (%), 2011-Q1 2015
  • Expenditure on magazine advertising of the pharmaceutical sector in Poland (PLN m) and change (%), 2011-Q1 2015
  • Expenditure on newspaper advertising of the pharmaceutical sector in Poland (PLN m) and change (%), 2011-Q1 2015
  • Share of individual manufacturers in press advertising expenditure on OTC drugs in Poland (%), 1 March-14 April 2015
  • Share of individual manufacturers in press advertising expenditure on dietary supplements in Poland (%), 1 March-14 April 2015
  • Expenditure on outdoor advertising of the pharma sector in Poland (PLN m) and change (%), 2006-Q1 2015
  • Market share of 10 largest manufacturers on the pharmacy OTC product market in Poland (%), by value, 2014
  • Number of dietary supplements in Hungary of which launch the National Institute for Food and Nutrition Science was notified, 2011-Jul 2015
  • Number of dietary supplements banned in Hungary and change (%), 2005-July 2015
  • Number of items on the list of drugs authorised to be sold at non-pharmacy outlets in Hungary, 2012-2015
  • Share of dietary supplements as a proportion of the total OTC product market in Hungary (%), by value, H1 2014
  • Share of OTC products as a proportion of the Hungarian pharmaceutical market (%), by value, 2014
  • Share of OTC products as a proportion of the pharmacy market in Hungary (%), 2007-2014
  • Change in value of Hungarian pharmacy market (%), by category, 2011-2014
  • Value (HUF bn) and change (%, y-o-y) of the OTC product market in Hungary, 2011-2020
  • Volume of the OTC drugs market in Hungary (million packets) and change (%), 2011-2014
  • Value (HUF bn) and change (%, y-o-y) of the dietary supplement pharmacy market in Hungary, 2005-2014
  • Average pharmacy drug prices in Hungary (HUF), 2014
  • Number of changes in status from prescription drug to OTC medication in Hungary, 2013-August 2015
  • Spending on advertising of OTC products in Hungary (HUF bn) and change (%), 2009-H1 2015
  • Top categories of OTC products in terms of TV advertising spending in Hungary (%), by value, 2014
  • OTC categories most advertised on TV in Hungary, by number of advertisements, 2014
  • Top categories of OTC products in terms of TV advertising spending in Hungary (%), by value, H1 2015
  • OTC categories most advertised on TV in Hungary, by number of advertisements, H1 2015
  • Permits for new drug market launches in Romania, 2012-2014
  • Total number of dietary supplements in Romania of which launch the IBA was notified, 2005-2014
  • Pharmacy sales of OTC products in Romania, by product status and market share (%), 2014
  • Share of OTC products as a proportion of the Romanian pharmacy market (%), by value, 2013-Q1 2015
  • Share of OTC products as a proportion of the Romanian pharmacy market (%), by volume, 2011-Q1 2015
  • Value (RON bn) and change (%, y-o-y) of the OTC products market in Romania, 2009-2020
  • Value (RON m) and change (%, y-o-y) of the dietary supplements pharmacy market in Romania, 2005-2014
  • Average price per packet of OTC products in Romania (RON), 2013-2014
  • Number of changes in status from prescription drug to OTC medication in Romania, 2013-August 2015
  • 10 leading radio pharmaceuticals and healthcare services advertisers in Romania, by card value (€ m), H1 2015
  • Most popular radio stations for advertising of pharmaceuticals and healthcare services in Romania, by card value (€ m), H1 2015
  • Number of dietary supplements in the Czech Republic of which launch the National Institute of Public Health was notified and change (%), 2007-2014
  • Behaviour of professionally active Czechs in cases of flu and viral diseases, by sex (%), 2015
  • Percentage of people who have bought an OTC drug or dietary supplement while influenced by an advertisement in the Czech Republic (%), 2015
  • Proportion of overweight male population in 15 most prominent countries (%), 2030
  • Places where dietary supplements are purchased by Czechs (%), 2015
  • Reasons for buying OTC drugs and dietary supplements online among Czechs (%), February 2015
  • Reasons for not buying OTC drugs and dietary supplements online among Czechs (%), February 2015
  • Frequency of online purchases of medicines in the Czech Republic (%), 2015
  • Share of OTC drugs and dietary supplements as a proportion of the OTC pharmacy product market in the Czech Republic (%), by volume, 2007 – H2 2012-H1 2013
  • Share of OTC drugs and dietary supplements as a proportion of the OTC pharmacy product market in the Czech Republic (%), by value, 2013-2014
  • Share of OTC drugs and dietary supplements as a proportion of the Czech pharmaceutical market (%), pharmacy sales, by volume, September 2013-August 2014
  • Share of OTC drugs and dietary supplements as a proportion of the Czech pharmaceutical market (%), pharmacy sales, by value, 2014
  • Value (CZK bn) and change (%, y-o-y) of the OTC product market in the Czech Republic, 2008-2020
  • Number of packets of OTC drugs sold in the Czech Republic (million), 2009-Q1 2015
  • Value (CZK bn) and change (%, y-o-y) of the dietary supplements pharmacy market in the Czech Republic, 2009-2014
  • Average manufacturer price per packet of OTC drugs in the Czech Republic (CZK) and change (%), 2009-Q1 2015
  • Average price per packet of selected bestselling OTC drugs in the Czech Republic (CZK), 2014
  • Average price per packet of selected bestselling OTC drugs in the Czech Republic (CZK), Q1 2015
  • Number of Rx to OTC switches in the Czech Republic, 2010-2013
  • Spending on OTC products advertising in the Czech Republic (CZK m), by product category, 2010-February 2014
  • Attitudes of Czechs towards OTC drug advertising, 2015
  • Spending on pharmaceutical product internet advertising in the Czech Republic (CZK m), selected months of 2013 and 2014
  • Attitudes towards flu vaccination among GPs in Bulgaria (%), 2013
  • Ways of preventing illness in Bulgaria (%), 2014
  • Percentage of children with weight disorders in Bulgaria (%), 2008 and 2014
  • New authorisations for OTC drugs in Bulgaria, 2011 – January-May 2015
  • New OTC drugs authorised in Bulgaria, 2011 – January-May 2015
  • Proportion of overweight female population in 15 most prominent countries (%), 2030
  • Share of OTC products as a proportion of the Bulgarian pharmaceutical market (%), by value, 2013
  • Value (BGN m) and change (%, y-o-y) of the OTC product market in Bulgaria, 2009-2020
  • Rate of growth of pharmacy sales of OTC drugs and non-drugs in Bulgaria (%), 2010/2009-2014/2013
  • Value (BGN m) and change (%, y-o-y) of the OTC drugs market in Bulgaria, 2009-2014
  • Value (BGN m) and change (%) of the dietary supplements pharmacy market in Bulgaria, 2009-2014
  • Largest OTC drug categories in Bulgaria, by value (BGN m), 2014
  • Largest OTC non-drug categories in Bulgaria, by value (BGN m), 2014
  • Change in sales in selected dietary supplement categories in Bulgaria (%), by value, 2014
  • Average pharmacy prices of OTC products in Bulgaria (BGN), 2013-2014
  • Number of changes in status from prescription drug to OTC medication in Bulgaria, 2011 – January-October 2014
  • Advertising spending of pharmaceutical companies in selected media in Bulgaria (BGN m), 2012-Q1 2015
  • Number of acute respiratory infections and flu cases in Slovakia (‘000), 2009-2015
  • Frequency of purchase of OTC painkillers in Slovakia (%), 2015
  • Most popular criteria influencing OTC painkiller purchases in Slovakia (%), 2015
  • Number of OTC painkiller brands purchased in the last 12 months in Slovakia (%), 2015
  • Brand loyalty in OTC painkiller purchases in Slovakia (%), 2015
  • Share of OTC products as a proportion of the Slovak pharmaceutical market (%), by volume, 2013
  • Value (€ m) and change (%, y-o-y) of the OTC product market in Slovakia, 2008-2020
  • Value (€ m) and change (%, y-o-y) in the dietary supplement pharmacy market in Slovakia, 2007-2014
  • Volume of dietary supplement pharmacy sales in Slovakia (million packets), 2007 – Q4 2012-Q3 2013
  • Average manufacturer price per packet of dietary supplements in Slovakia (€), 2007-2013
  • Advertising spending on medicines in Slovakia (€ m) and change (%, y-o-y), 2013-2014
  • Krka Group employee breakdown, by regions, 2014
  • Krka global revenues and net profit (€ m), 2005-H1 2015
  • Share of new products as a proportion of Krka’s total sales value (%), 2009-2014
  • Krka global revenues from OTC products (€ m) and y-o-y change (%), 2011-H1 2015
  • Share of Krka sales as a proportion of the total global market, by region (%), 2014-H1 2015
  • Krka sales in CE countries analysed (€ m), 2013-Q1 2015
  • Krka global OTC sales (%), by product groups, 2014
  • Sopharma global revenues and net profit (€ m), 2008-H1 2015
  • Sopharma Group sales revenues from finished products, by pharmaceutical form (%), H1 2015
  • Sopharma AD sales revenues, by pharmaceutical form (%), H1 2015
  • Sopharma Group global revenues (€ m), by geographical market, 2013-H1 2015
  • Sopharma AD sales revenues (€ m), 2013-H1 2015
  • Sopharma AD global revenues (€ m), by geographical market, 2013-H1 2015
  • Sopharma AD sales revenues, by country and region (%), 2014-H1 2015
  • USP Zdrowie revenue and net profit (€ m), 2011-2014
  • US Pharmacia revenue and net profit (€ m), 2009-2014
  • Product structure of USP Zdrowie/US Pharmacia in Poland, by number of products in specific categories (%), June 2015
  • Number of Walmark employees in CE countries analysed, 2014
  • Walmark Group revenues (€ m) and change (%, y-o-y), 2011/2012-2013/2014
  • Walmark sales revenues in Slovakia (€ m) and change (%, y-o-y), 2010-2014
  • Walmark sales revenues in Poland (€ m) and change (%, y-o-y), 2008/2009-2013/2014
  • Walmark sales revenues in Romania (€ m) and change (%, y-o-y), 2010-2014
  • Walmark sales revenues in Hungary (€ m) and change (%, y-o-y), 2010-2014
  • Walmark sales revenues (€ m) and change (%, y-o-y) in Bulgaria, 2008-2013

Tables

  • Average OTC price in Western Europe and CEE and change (€ per pack), 2012-2014
  • Most important events, reforms and market trends, and their impact on the OTC market in Poland, 2014-2015
  • Number of GIS notifications of the first market placement of dietary supplements in Poland, 2013-2015
  • Parallel imports of medical products admitted for trading in Poland, 2014
  • Parallel imports of medical products admitted for trading in Poland, January-April 2015
  • Sales value, change and market share for dietary supplements coming from parallel imports in Poland, Q1 2013-Q1 2015
  • Sales value, change and market share for OTC drugs coming from parallel imports in Poland, Q1 2013-Q1 2015
  • Future market reforms and changes and their impact on the OTC market in Poland, 2015-2020
  • Pharmacy sales of selected OTC product categories in Poland (PLN m) and y-o-y change (%), final consumer prices, January-November 2014  
  • Pharmacy sales of selected OTC drug categories Poland (PLN m) and y-o-y change (%), final consumer prices, Q1 2015        
  • OTC product market in Poland, by main product categories (PLN bn), 2012-2020
  • Pharmacy sales of selected dietary supplement categories in Poland (PLN m), 2014
  • Pharmacy sales of selected dietary supplement categories in Poland (PLN m) and y-o-y change (%), Q1 2015
  • Average price of OTC drugs and dietary supplements per packet in Poland (PLN) and change (%), 2009-2014
  • Switches in the availability category from Rx to OTC in Poland, 2014
  • Switches in availability category from Rx to OTC in Poland, January-August 2015
  • 30 bestselling OTC products in Poland, by sales value, 2014
  • 30 bestselling OTC drugs in Poland, by value, 2014
  • Bestselling dietary supplements (brands) in Poland, by value, 2014
  • Advertising spending of leading pharmaceutical manufacturers in Poland (PLN m), January-October 2013-2014
  • Advertising spending of leading pharmaceutical manufacturers in Poland (PLN m) and y-o-y change (%), Q1 2014 and Q1 2015
  • Advertising expenditures on pharma brands in Poland (PLN m), January-October 2013-2014
  • Expenditure on TV advertising of selected pharma industry manufacturers in Poland (PLN), 2013-Q1 2015
  • 10 most often advertised OTC products in TV in Poland, by number spots, 2014
  • Expenditures of selected manufacturers on radio advertising in the pharmaceutical sector in Poland (PLN), 2013-2014
  • Share of individual manufacturers as a proportion of radio advertising spending on OTC drugs in Poland (%), 1 March-14 April 2015
  • Share of individual manufacturers as a proportion of radio advertising spending on dietary supplements in Poland (%), 1 March-14 April 2015
  • Estimated expenditure of the pharmaceutical industry on online advertising (PLN m) and share in total online advertising market in Poland (%), 2012-2014
  • Value of pharmacy sales (PLN m) and change (%) for 10 largest holdings in the OTC market in Poland, Q1 2015
  • Pharmacy sales value (PLN m) and change (%) for 10 largest manufacturers on the dietary supplement market in Poland (PLN m), 2011-2014
  • Market share of 10 largest manufacturers on the pharmacy dietary supplement market in Poland (%), by value, 2012-2014
  • Selected acquisitions of pharmaceutical companies in the OTC segment in Poland, 2013-September 2015
  • Possible acquisitions in the OTC segment in Poland, from Q4 2015
  • Selected investment in the OTC manufacturing sector in Poland, 2013-2015
  • Selected planned investment in the OTC manufacturing sector in Poland, 2015-2024
  • Expansion of the OTC product portfolio planned by manufacturers in Poland, from 2015
  • Main trends and events, and their effect on the OTC market in Hungary, 2014-2015
  • OTC drugs introduced to non-pharmacy sale in Hungary, 2013-May 2015
  • Frequency of purchase of medicines, vitamins and dietary supplements via the internet in Hungary (%), 2013-2015
  • Anticipated trends and events and their effect on the OTC market in Hungary, 2015-2020
  • OTC drugs market in Hungary, by main product categories (€ m), 2013-2020
  • Average price of dietary supplements in Hungary in comparison with OTC products (HUF), January 2008 and January 2014
  • Rx-to-OTC switches in Hungary, 2013-August 2015
  • Bestselling OTC drugs in Hungary, by value (HUF bn), 2014
  • Advertising spending of pharmaceutical manufacturers in Hungary (HUF bn) and change (%), by channel, 2012-2014 and H1 2015
  • Spending on OTC products advertising in Hungary in comparison with total market (%), by channel, 2014
  • Spending on OTC products advertising in Hungary in comparison with total market (%), by channel, H1 2015
  • Leading advertisers of OTC brands in Hungary, by amount spent (HUF bn), 2014
  • Leading advertisers of OTC brands in Hungary, by amount spent (HUF bn), H1 2015
  • Leading OTC products in Hungary by amount spent on advertising (HUF bn), 2014
  • Leading OTC products in Hungary by amount spent on advertising (HUF bn), H1 2015
  • Top 10 manufacturers of OTCs in Hungary, by value, 2014
  • Top 10 manufacturers of dietary supplements in Hungary, by value (HUF), July 2013-June 2014
  • Main trends and events, and their effect on the OTC market in Romania, 2013-2015
  • Total number of dietary supplements in Romania of which launch the IBA and other institutions were notified, by July 2015
  • Anticipated events and trends, and their effect on the OTC market in Romania, 2015-2020
  • Comparison between changes in sales and number of products on the Rx and OTC market in Romania, 2014/2008
  • OTC product market in Romania, by main product categories (RON m), 2011-2020
  • Rx-to-OTC switches in Romania, 2013-August 2015
  • Top 20 bestselling OTC drugs in Romania, by sales value (€ m), Q1-Q3 2013 and Q1-Q3 2014
  • Top 9 bestselling OTC drugs manufactured in Romania, by sales value (RON m), Q1-Q3 2013 and Q1-Q3 2014
  • Top 10 bestselling OTC drugs in Romania, by sales value (€ m), 2014
  • Top 10 bestselling OTC drugs in Romania (RON m), Q2 2014-Q1 2015
  • Leading TV advertisers of OTC products in Romania (GRP), January-July 2015
  • Leading internet advertisers of OTC products in Romania (€ m), January-July 2015
  • Top 10 manufacturers of OTC products in Romania, by sales value (€ m), 2013
  • Main past events and trends, and their effect on the OTC market in the Czech Republic, 2013-2015
  • Breakdown of revenues in pharmacies located in and outside medical facilities in the Czech Republic (%), 2013
  • Attitudes towards reimbursement of alternative medicine among patients in the Czech Republic (%), 2014
  • Frequency of buying OTC drugs and dietary supplements in the Czech Republic (%), 2015
  • Frequency of buying dietary supplements in the Czech Republic (%), 2015
  • Most important factors which influence OTC purchases in the Czech Republic (%), 2015
  • Most important factors influencing purchases of dietary supplements among Czechs (%), 2015
  • Percentage of people who have noticed OTC advertisements in the Czech Republic (%), by category of media, 2015
  • Anticipated trends and events, and their effect on the OTC market in the Czech Republic, 2015-2030
  • Opinions on the expansion of sales of medicines to places other than pharmacies among Czechs (%), by sex, 2015
  • Main growth drivers of OTC market in the Czech Republic, 2014
  • OTC market in the Czech Republic, by main product categories (%), September 2013-August 2014
  • OTC market in the Czech Republic, by main product categories (CZK bn), 2012-2020
  • Selected 15 bestselling OTC drugs in the Czech Republic, wholesale sales, by value (CZK m), 2014
  • Bestselling OTC products on dry cough in the Czech Republic, by value, 2014
  • Selected 15 bestselling OTC drugs in the Czech Republic, wholesale sales, by value (CZK m), Q1 2015
  • Bestselling OTC products at a sample online pharmacy in the Czech Republic, by value, July 2015
  • Bestselling 15 OTC drugs in the Czech Republic, wholesale sales, by volume (‘000 packets), 2014
  • OTC products most recommended by pharmacists in the Czech Republic in selected product categories (%), 2014
  • Bestselling 15 OTC drugs in the Czech Republic, wholesale sales, by volume (‘000 packets), Q1 2015
  • Changes in medicinal status (Rx to OTC switch) in the Czech Republic, 2013
  • Top 10 manufacturers of OTC products in the Czech Republic, by value (CZK m), Q1 2015
  • Top 10 manufacturers of OTC products in the Czech Republic, by value (CZK m), Q2 2014-Q1 2015
  • Valosun financial results (CZK m), 2012-2014
  • Main past events and trends, and their effect on the OTC market in Bulgaria, 2013-2015
  • Number of OTC drugs registered in Bulgaria, by most popular ATC categories, June 2015
  • Anticipated trends and events, and their effect on the OTC market in Bulgaria, 2015-2030
  • Volume (million packets) and y-o-y change (%) of the OTC product market in Bulgaria, 2011-2014
  • Sales value of main OTC drug categories in Bulgaria (€ m), 2009-2020
  • Rx-to-OTC switches in Bulgaria, 2013-2014
  • Most popular antitussives in Bulgaria, November-December 2014
  • Most commonly preferred analgesics in Bulgaria, November-December 2014
  • Most commonly preferred analgesics and antipyretic products for children in Bulgaria, November-December 2014
  • Most commonly preferred cardioprotectors for children in Bulgaria, November-December 2014
  • Most widely preferred antiallergic products in Bulgaria, November-December 2014
  • Most widely preferred antidiarrheal products in Bulgaria, November-December 2014
  • Most widely preferred antihistamines for topical application in Bulgaria, November-December 2014
  • Most widely preferred anti-cellulite products in Bulgaria, November-December 2014
  • Most widely preferred products for children in Bulgaria, November-December 2014
  • Most widely preferred vitamins for pregnant women in Bulgaria, November-December 2014
  • 10 bestselling dietary supplements in Bulgaria, by value, H1 2015
  • Top 20 advertisers of OTC drugs and dietary supplements, in terms of value (BGN m), 2013-2014
  • Top 10 advertisers of OTC drugs and dietary supplements, in terms of value (BGN m), H1 2014-H1 2015
  • Top 10 brands of OTC products in terms of advertising spending in Bulgaria, by amount spent (BGN m), 2013-2014
  • Leading pharmaceutical advertisers on TV in Bulgaria, Q1 2015
  • Sales value (BGN m) and market share (%) of top 10 manufacturers of OTC products in Bulgaria, 2012
  • Sales volume (million packets) and market share (%) of selected leading manufacturers of OTC products in Bulgaria, 2012
  • Sales value (BGN m) and market share of top 10 manufacturers of OTC drugs in Bulgaria, 2012
  • Top 10 manufacturers on the pharmacy dietary supplement market in Bulgaria (%), by value, H1 2015
  • Financial results of top 10 producers/importers of dietary supplements in Bulgaria, 2013-2014
  • Main past trends and events, and their effect on the OTC market in Slovakia, 2013-2015
  • Percentage of people vaccinated against flu in Slovakia (%), 2004/2005-2013/2014
  • Awareness of, and loyalty to, particular brands of OTC painkillers in Slovakia (%), 2015
  • Pharmacy purchases among Slovaks, by product category and location, 2015
  • Anticipated trends and events, and their effect on the OTC market in Slovakia, 2015-2020
  • Main growth factors of OTC market in Slovakia, 2014
  • Number of packets of OTCs sold in Slovakia (million) and change (%), April 2014-March 2015
  • Consumption of reimbursed dietary supplements in Slovakia, 2012-2014
  • OTC product market in Slovakia, by main product categories (€ m), 2011-2020
  • OTC product pharmacy market in Slovakia, by main categories (%), by value, 2014
  • OTC drug pharmacy market in Slovakia, by main ATC categories (%), by value, 2013-2014
  • Sales value of OTC drugs in Slovakia, by main ATC categories (€ m), 2013-2014
  • OTC drug pharmacy market in Slovakia, by main ATC categories (%), by volume, 2013-2014
  • Sales volume of OTC drug categories in Slovakia, by main ATC categories (million packets), 2013-2014
  • Sales value (€) and volume ('000) of OTC drugs in Slovakia, by 2-level ATC categories, 2014
  • Sales value (€), volume (packets) and shares of homeopathic OTC drugs in Slovakia, 2014
  • Average price per packet of OTC drugs in Slovakia (€), by ATC category, 2013-2014
  • Average prices per packet of selected bestselling OTC drugs in Slovakia (€), 2014
  • Selected 10 bestselling OTC drugs in Slovakia, by value (€ m), 2014
  • Selected 10 bestselling OTC drugs in Slovakia, by value (€ m), Q1 2015
  • 25 bestselling OTC drugs in Slovakia, by volume ('000), 2014
  • 25 bestselling OTC drugs in Slovakia, by volume ('000), Q1 2015
  • OTC products most commonly recommended by pharmacists in Slovakia in selected product categories (%), 2014
  • Data on SUKL activity in the area of drug advertising in Slovakia, 2007-2014
  • General information pertaining to the marketing and promotional costs of pharmaceutical companies in Slovakia, 2012-2013
  • Top 10 advertisers of OTC cold/flu drugs in Slovakia, 2014
  • Most widely advertised OTC cold/flu drugs in Slovakia, 2014
  • Top 10 manufacturers of OTC drugs in Slovakia, by value (€ m), at manufacturer prices, 2010-H1 2015
  • Top 10 manufacturers of OTC drugs in Slovakia, by volume (’000), 2010-H1 2015
  • General information pertaining to Bayer HealthCare, 2015
  • Sales of individual Bayer companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to Bayer product portfolio, 2015
  • General information pertaining to Berlin-Chemie/Menarini, 2015
  • Sales of individual Berlin-Chemie/Menarini companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to Berlin-Chemie/Menarini product portfolio, 2015
  • General information pertaining to GlaxoSmithKline, 2015
  • Sales of individual GSK companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to GSK product portfolio, 2015
  • General information pertaining to Krka, 2015
  • Ownership structure of Krka (%), 2015
  • Structure of Krka in CE countries analysed, 2015
  • Krka's sales of OTC products in selected CE countries (€ m), 2011-2014
  • Krka sales breakdown, by product or category of service (€ m), and change (y-o-y, %), 2014
  • Krka global sales (€ m), by region, 2012-H1 2015
  • General information pertaining to Krka product portfolio in CE countries analysed, 2015
  • Most substantial increases in sales value of Krka’s OTC products (%), H1 2015
  • General information pertaining to sales of Krka OTC products in Poland, 2015
  • General information pertaining to sales of Krka’s OTC products in the Czech Republic, 2015
  • General information pertaining to sales of Krka’s OTC products in Romania, 2015
  • General information pertaining to sales of Krka’s OTC products in Hungary, 2015
  • General information pertaining to sales of Krka’s OTC products in Slovakia, 2015
  • General information pertaining to sales of Krka’s OTC products in Bulgaria, 2015
  • General information pertaining to Novartis/Sandoz, 2015
  • Sales of individual Novartis/Sandoz companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to Novartis/Sandoz product portfolio, 2015
  • General information pertaining to Sanofi, 2015
  • Sales of individual Sanofi companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to Sanofi product portfolio, 2015
  • General information pertaining to Sopharma, 2015
  • Ownership structure of Sopharma AD (%), July 2015
  • Selected companies in Sopharma Group in CE countries analysed, Q1 2015
  • Structure of Sopharma in CE countries analysed, 2015
  • Total area (m²) and number of employees at selected Sopharma manufacturing plants in Bulgaria, 2014
  • Breakdown of Sopharma AD sales revenue by major ATC codes (BGN ‘000) in H1, 2014 and 2015
  • General information pertaining to Sopharma product portfolio, 2014
  • General information pertaining to Teva, 2015
  • Sales of individual Teva companies registered in selected CE countries (€ m), 2013 or 2014
  • General information pertaining to Teva product portfolio, 2015
  • General information pertaining to US Pharmacia/USP Zdrowie, 2015
  • Ownership structure of US Pharmacia (%), October 2014
  • Ownership structure of USP Zdrowie (%), 2015
  • Structure of US Pharmacia in CE countries analysed, 2015
  • General information pertaining to USP Zdrowie product portfolio, 2015
  • General information pertaining to Walmark, 2015
  • Ownership structure of Walmark (%), 2014
  • Structure of Walmark in CE countries analysed, 2015
  • General information pertaining to Walmark product portfolio, 2014
  • General information pertaining to sales of Walmark OTC products in the Czech Republic, 2015
  • Walmark a.s. turnover (€ m), and change (% y-o-y), 2007/2008-2012/2013
  • General information pertaining to sales of Walmark OTC products in Slovakia, 2015
  • General information pertaining to sales of Walmark OTC products in Poland, October 2014
  • General information pertaining to sales of Walmark OTC products in Romania, 2015
  • General information pertaining to sales of Walmark OTC products in Hungary, October 2015
  • General information pertaining to sales of Walmark OTC products in Bulgaria, 2015